Northwestern Mutual Investment Management Company LLC boosted its position in MAXIMUS, Inc. (NYSE:MMS) by 56.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 13,346 shares of the health services provider’s stock after acquiring an additional 4,815 shares during the quarter. Northwestern Mutual Investment Management Company LLC’s holdings in MAXIMUS were worth $891,000 at the end of the most recent reporting period.
A number of other large investors have also recently made changes to their positions in MMS. Teacher Retirement System of Texas increased its stake in MAXIMUS by 314.4% in the fourth quarter. Teacher Retirement System of Texas now owns 22,179 shares of the health services provider’s stock valued at $1,588,000 after acquiring an additional 16,827 shares during the last quarter. California Public Employees Retirement System increased its stake in MAXIMUS by 3.4% in the fourth quarter. California Public Employees Retirement System now owns 108,188 shares of the health services provider’s stock valued at $7,744,000 after acquiring an additional 3,601 shares during the last quarter. Swiss National Bank increased its stake in MAXIMUS by 2.3% in the fourth quarter. Swiss National Bank now owns 110,507 shares of the health services provider’s stock valued at $7,910,000 after acquiring an additional 2,500 shares during the last quarter. New Mexico Educational Retirement Board bought a new position in MAXIMUS in the fourth quarter valued at approximately $1,152,000. Finally, The Manufacturers Life Insurance Company increased its stake in MAXIMUS by 9.0% in the fourth quarter. The Manufacturers Life Insurance Company now owns 154,243 shares of the health services provider’s stock valued at $11,040,000 after acquiring an additional 12,717 shares during the last quarter. 93.86% of the stock is currently owned by institutional investors and hedge funds.
In other MAXIMUS news, Director Russell A. Beliveau sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, April 2nd. The shares were sold at an average price of $66.55, for a total value of $66,550.00. The sale was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 3.10% of the company’s stock.
Shares of MAXIMUS opened at $63.23 on Friday, Marketbeat reports. MAXIMUS, Inc. has a fifty-two week low of $58.58 and a fifty-two week high of $72.71. The company has a market capitalization of $4.14 billion, a price-to-earnings ratio of 19.81, a P/E/G ratio of 2.44 and a beta of 1.11.
MAXIMUS (NYSE:MMS) last issued its earnings results on Thursday, May 10th. The health services provider reported $0.82 earnings per share for the quarter, missing analysts’ consensus estimates of $0.84 by ($0.02). MAXIMUS had a net margin of 9.15% and a return on equity of 21.67%. The company had revenue of $612.79 million during the quarter, compared to analyst estimates of $617.97 million. During the same quarter in the prior year, the business earned $0.80 EPS. The business’s quarterly revenue was down 1.5% on a year-over-year basis. equities research analysts expect that MAXIMUS, Inc. will post 3.24 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Thursday, May 31st. Shareholders of record on Tuesday, May 15th were given a $0.045 dividend. The ex-dividend date of this dividend was Monday, May 14th. This represents a $0.18 dividend on an annualized basis and a yield of 0.28%. MAXIMUS’s dividend payout ratio is currently 5.94%.
A number of research analysts recently issued reports on the stock. First Analysis raised shares of MAXIMUS from an “equal” rating to a “weight” rating and lifted their price objective for the company from $73.00 to $81.00 in a research note on Tuesday, May 8th. Zacks Investment Research cut shares of MAXIMUS from a “hold” rating to a “sell” rating in a research note on Tuesday, May 22nd. Finally, Canaccord Genuity decreased their price objective on shares of MAXIMUS from $65.00 to $64.00 and set a “hold” rating on the stock in a research note on Friday, May 11th. Two equities research analysts have rated the stock with a sell rating and three have issued a hold rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $71.00.
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews.
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.